Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4817 - 4824 of 11616 results
The Bubbler
April 12, 2019| Blog| Viewpoint
Government Regulation of Drug Pricing and the Evolving Pharmaceutical Supply Chain
April 12, 2019| Video| Viewpoint
Key Takeaways from DOJ’s Anti-Steering Case against Atrium Health
April 12, 2019| Video| Viewpoint
CFIUS Review and International Business Transactions
April 12, 2019| Video| Viewpoint
Long Term Care in the United States
April 12, 2019| Video| Viewpoint
Massachusetts Paid Family and Medical Leave Part 2: Key Differences in the Revised Regulations
April 11, 2019| Blog| Viewpoint
Update on Energy Storage and Offshore Wind Initiatives in New York
April 11, 2019| Blog| Viewpoint
Mintz's Christopher Harvie Honored as Cablefax Top Lawyer
April 11, 2019| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.